Merrimack Pharmaceuticals - Dividend History | MACK

Historical dividend payout and yield for Merrimack Pharmaceuticals (MACK) since 2019. The current TTM dividend payout for Merrimack Pharmaceuticals (MACK) as of April 18, 2019 is $0.00. The current dividend yield for Merrimack Pharmaceuticals as of April 18, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.080B $0.144B
Merrimack Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery, development and preparation to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with a special focus on cancer. Merrimack Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.312B 12.32
Gilead Sciences (GILD) United States $80.293B 10.22
Bio-Techne Corp (TECH) United States $7.144B 48.13